Compugen reported $-6.94M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
aTyr Pharma USD -25.75M 6.22M Sep/2025
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD -6.94M 421K Sep/2025
RedHill Biopharma USD -1.54M 12M Jun/2024